Author:
Watt H. L.,Rachid Z.,Jean-Claude B. J.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference51 articles.
1. Merayo N, Rachid Z, Qiu Q, Brahimi F, Jean-Claude BJ (2006) The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo. Anticancer Drugs 17:165–171
2. Banerjee R, Rachid Z, McNamee J, Jean-Claude BJ (2003) Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a novel tumor targeting concept. J Med Chem 46:5546–5551
3. Qiu Q, Dudouit F, Matheson SL, Brahimi F, Banerjee R, McNamee JP, Jean-Claude BJ (2003) The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties. Cancer Chemother Pharmacol 51:1–10
4. Brahimi F, Matheson SL, Dudouit F, McNamee JP, Tari AM, Jean-Claude BJ (2002) Inhibition of epidermal growth factor receptor-mediated signaling by “Combi-triazene” BJ2000, a new probe for Combi-Targeting postulates. J Pharmacol Exp Ther 303:238–246
5. Matheson SL, McNamee JP, Jean-Claude BJ (2001) Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy. J Pharmacol Exp Ther 296:832–840
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献